Quest Diagnostics Strikes Generative AI Partnership with Google Cloud

Posted Friday, March 21, 2025 5:52 pm

Katie Adams (via MedCity News)

Quest Diagnostics teamed up with Google Cloud. The collaboration seeks to deliver new AI capabilities — including predictive population health analytics, customized physician results reporting and individualized patient engagement. The post Quest Diagnostics Strikes Generative AI Partnership with Google Cloud appeared first on MedCity News.

Continue reading at MedCity News »

Keywords

Artificial Intelligence, Devices & Diagnostics, Diagnostics, big tech, generative AI, Google Cloud, Quest Diagnostics

Top stories

My Doctor Saved My life, Diabetes Tech Gave Me Control

(NewsUSA) - Troy Ita’s life was turned upside down by diabetes. Thankfully, he doesn’t have to compromise lifestyle or family time with the help of groundbreaking technology. Family is at the …

Sunscreen: You’re Not Fully Dressed Without It

(NewsUSA) - If you put on socks this morning but skipped the sunscreen, you’re doing it wrong — at least according to a new nationwide campaign launched on World Health Day earlier this …

Step Into Spring – Don't Let Varicose Veins Stop You

(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of …

Spring Into Action – Don't Let Varicose Veins Hold You Back

(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of …

Expanding Coverage for FDA-Approved GLP-1s Is Critical for Patient Safety

(NewsUSA) - The newest generation of GLP-1 drugs has delivered life-changing benefits to patients managing diabetes, obesity, heart disease, and other chronic health conditions. And yet even though …

From the web

Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease

The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the …

Women’s Health is Having Its Moment – It’s Time for the System to Catch Up

Too many women have experienced the impacts of living with gynecological conditions while feeling dismissed and struggling to get care. Women deserve better, and as we collectively challenge outdated …

Drug-Gene Testing: Key to Safer Cancer Treatment

Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it’s encouraging that regulatory bodies and professional organizations are …

How Are Hospitals Bracing for Tariffs?

The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already …

Why UnitedHealth Group’s Shares Have Taken a Tumble

UnitedHealth Group’s shares fell by over 22% on Thursday after its first quarter earnings. This is largely due to challenges in its Medicare Advantage business. The post Why UnitedHealth …